bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.10.21.683692

Canonical Hidden Markov Model Networks for Studying M/EEG

Abstract

Dynamic brain networks identified in magneto/encephalography (M/EEG) recordings provide new insights into human brain activity. One established method uses Hidden Markov Models (HMMs) and has been shown to infer reproducible, fast-switching brain networks in a variety of cognitive and disease conditions. Often these studies are done on small bespoke (boutique) datasets (N < 100) and analysed in isolation of other M/EEG datasets. Instead of training a new model for each boutique study, which is computationally expensive, we propose the use of a canonical HMM. This provides a common reference through which different studies can be described using the same set of networks. We provide HMMs for a range of model orders (4-16 states) in parcellated source space and sensor space. These HMMs were trained on 1849 MEG recordings (N = 621, 18-88 years old, 194 hours), capturing population variability in both rest and task data. We illustrate applications of this canonical HMM approach in parcellated source space using boutique MEG and EEG datasets. Applying the canonical HMM in parcel space requires the boutique dataset to be preprocessed and source reconstructed in the same way as the canonical HMM training data. Applying the canonical HMM in the sensor space requires the same sensor layout and preprocessing as the canonical HMM training data. The canonical HMMs have been made publicly available as an open-access resource, providing sets of canonical brain networks that can be used to compare individuals within and across a range of datasets. HighlightsO_LIInstead of training a new HMM for every study, which is computationally expensive and can lead to less reliable results, we propose a canonical HMM instead. C_LIO_LIThe canonical HMM provides a common reference through which different studies can be described using the same set of networks. C_LIO_LIThe canonical HMM was learnt from 1849 MEG recordings (194 hours of data; resting state and task) in participants aged 18-88 years. C_LIO_LIWe demonstrate applications of the canonical HMM on three parcellated source space boutique studies: an Alzheimers resting-state MEG dataset, a working memory task MEG dataset, and a resting-state EEG dataset. C_LIO_LIWe transfer the parcel-level canonical HMM to sensor space, avoiding the need for source reconstruction. C_LIO_LIWe release the canonical HMM (for varying model orders) as an open-access resource for M/EEG research. C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gohil, C., Huang, R., Higgins, C., van Es, M. W. J., Quinn, A. J., Vidaurre, D., Woolrich, M. W.. 2025-10-22. Canonical Hidden Markov Model Networks for Studying M/EEG. https://doi.org/10.1101/2025.10.21.683692

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗